Clomid (clomiphene citrate) causes side effects in a significant number of users, with hot flashes being the most common at about 10% of women. Most side effects are mild and resolve after you stop taking the medication, but some, like mood changes and visual disturbances, deserve closer attention. Here’s what to expect.
The Most Common Physical Side Effects
FDA clinical trial data from over 8,000 women provides a clear picture of how frequently the main side effects occur. Hot flashes affect roughly 1 in 10 users, making them the single most reported complaint. Abdominal bloating, pelvic discomfort, or a feeling of distention comes next at 5.5%. Breast tenderness or discomfort affects about 2% of users.
Nausea is also relatively common, though less precisely tracked in the clinical data. These physical symptoms tend to appear during the days you’re actively taking the medication (typically a five-day window early in your cycle) and fade within a week or two afterward. They’re driven by the way Clomid works: it blocks estrogen receptors in the brain, which triggers your body to ramp up ovulation-stimulating hormones. That hormonal shift is what causes the hot flashes and bloating.
Mood Swings and the “Clomid Crazies”
The emotional side effects of Clomid are common enough that fertility communities have coined the term “Clomid crazies.” A 2005 study found that 40% of women taking clomiphene experienced psychological side effects, including mood swings, irritability, and feeling down. That’s a substantial portion of users, and the effects can catch you off guard if you aren’t expecting them.
Some women describe feeling out of control or disconnected from reality. Insomnia, heightened anxiety, and sudden tearfulness are also reported. In rare cases, more serious psychiatric effects like psychosis have occurred. The emotional intensity typically lines up with the days you’re taking the pills and the days immediately following, though some women notice it lingering through more of their cycle. If you’ve had depression or anxiety before starting treatment, it’s worth being aware that Clomid can amplify those patterns.
Effects on Cervical Mucus and Uterine Lining
This is one of Clomid’s frustrating contradictions: while it successfully triggers ovulation, it can simultaneously work against pregnancy in other ways. Clomid blocks estrogen receptors not just in the brain but throughout the body, including the cervix and uterus. The result is a measurable reduction in cervical mucus quality and sperm-mucus interaction, making it harder for sperm to reach the egg even though an egg has been released.
The uterine lining is also affected. Research shows that Clomid significantly increases the prevalence of “out-of-phase” endometrium, meaning the lining isn’t developing in sync with the rest of the cycle. Women with suboptimal lining thickness after Clomid show patterns of reduced blood vessel growth and increased inflammation in the uterine tissue. This gap between ovulation rates and actual pregnancy rates is well recognized by fertility specialists, and it’s one reason some doctors add supplemental estrogen or switch to alternative medications after a few cycles.
Visual Disturbances
Blurred vision, seeing spots or flashes, and reduced visual sharpness are known risks with Clomid. For most women who experience these symptoms, they resolve after stopping the medication. However, regulatory agencies have flagged cases where visual changes were only partially reversible or, in rare instances, permanent. Reported complications include inflammation of the optic nerve, retinal detachment, and blockage of blood vessels in the retina, though these serious events are rare.
Visual symptoms are considered a signal to stop taking Clomid immediately. If you notice any change in your vision during a treatment cycle, including flickering lights, difficulty focusing, or dark spots in your field of view, that’s not something to push through.
Increased Chance of Twins
Clomid works by stimulating the ovaries to release eggs, and sometimes more than one egg matures and is released. In a large study of nearly 5,800 Clomid cycles, about 8% of resulting pregnancies were twins. Triplets occurred in roughly 0.4% of pregnancies. For context, the natural twin rate without fertility treatment is around 3%, so Clomid roughly doubles or triples that probability.
The twin rate stayed consistent regardless of the Clomid dose used, which suggests this is an inherent feature of how the drug works rather than something that scales with higher doses. Multiple pregnancies carry higher risks for both mother and babies, including preterm delivery and low birth weight, so this is worth factoring into your expectations.
Ovarian Hyperstimulation
Clomid can occasionally overstimulate the ovaries, causing them to swell and become painful. Mild ovarian enlargement is relatively common and resolves on its own, but in more pronounced cases you may feel significant pelvic pain, rapid weight gain from fluid retention, or abdominal swelling. Severe ovarian hyperstimulation syndrome (OHSS) is much more common with injectable fertility drugs than with Clomid, but it can still happen, particularly at higher doses or in women with polycystic ovary syndrome.
Long-Term Cancer Risk
Whether Clomid increases ovarian cancer risk has been debated for decades, and the current evidence is reassuring for most users. A review of the research found that using Clomid for less than one year is not associated with increased risk of ovarian tumors. Prolonged use beyond 12 months has been linked in some studies to a higher rate of borderline ovarian tumors, which are slow-growing and less aggressive than typical ovarian cancer.
The broader conclusion from the available research is that there is no definitive relationship between fertility drug use and cancer. Some individual observational studies have pointed to a possible link, but the overall body of evidence does not show a significant increase in cancer incidence from Clomid treatment. Most treatment protocols limit Clomid to three to six cycles, which falls well within the timeframe considered safe.